NCI | Technology Transfer

IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

Read more about IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

US Application 17/392,075
Filed on 2021-08-02

Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer

Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer

Israel
285335
Filed on 2021-08-03

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

Read more about Combination Therapy of Immunotoxin and Checkpoint Inhibitor

US Application 17/376,319
Filed on 2021-07-15

Methods To Eliminate Cancer Stem Cells By Targeting CD47

Read more about Methods To Eliminate Cancer Stem Cells By Targeting CD47

Australia
2021204818
Filed on 2021-07-09

T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY

Read more about T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY

Patent Cooperation Treaty
PCT/US2021/049387
Filed on 2021-09-08

T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3

Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3

Japan
2021-124003
Filed on 2021-07-29

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY

Read more about COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY

China
201980076357.9
Filed on 2019-09-20

Process For Preparing Z-Endoxifen Of High Purity

Read more about Process For Preparing Z-Endoxifen Of High Purity

Italy
16798855.9
Filed on 2016-10-24

Process For Preparing Z-Endoxifen Of High Purity

Read more about Process For Preparing Z-Endoxifen Of High Purity

United Kingdom
16798855.9
Filed on 2016-10-24

Process For Preparing Z-Endoxifen Of High Purity

Read more about Process For Preparing Z-Endoxifen Of High Purity

France
16798855.9
Filed on 2016-10-24

Subscribe to NCI